The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
_in_Mizushima,_Japan_256_384.jpg)
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
_256_384.jpg)
The collaboration aims to raise awareness about eye cancer, provide medical and surgical treatment support to children and supply nutritional supplements to aid in their faster recovery.
Cyanocobalamin Nasal Spray (RLD Nascobal) had estimated annual sales of USD 69 million in the U.S. (IQVIA MAT Mar 2023)
Subscribe To Our Newsletter & Stay Updated
